The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be
| Study Name on ClinicalTrials.gov (link is external) | Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) |
|---|---|
| Study Drug | Amikacin/ Tigecycline/ Imipenem/ Cefoxitin/ Azithromycin/ Clarithromycin/ Clofazimine/ Ethambutol/ Linezolid/ co-trimoxazole/ Doxycycline/ Moxifloxacin/ Bedaquiline/ Rifabutin |
| Type of Study Drug | Anti-Infective |
| Study Title | Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) |
| Study Phase | 2 and 3 |
| Study Sponsor | The University of Queensland |
| Participating ECFS-CTN sites | Please contact ecfs-ctn@uzleuven.be for most recent sitelist |
| Age | Pediatric and Adult patients |